Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Humoral hypercalcaemia of malignancy (HHM) commonly results from the excessive production of a parathyroid hormone-related protein (PTHrP) by tumours.
|
11044652 |
2000 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Humoral hypercalcemia of malignancy is believed to be induced when parathyroid hormone-related protein (PTHrP) is excessively produced in cancer cells and impairs the homeostasis of serum calcium concentrations.
|
11737483 |
2001 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Humoral hypercalcemia of malignancy (HHM), a paraneoplastic syndrome associated with epithelial cancers, including squamous cell carcinoma (SCC), is due to expression and secretion of parathyroid hormone-related protein (PTHrP).
|
11911944 |
2002 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) was originally identified as the tumor factor responsible for a clinical syndrome known as humoral hypercalcemia of malignancy.
|
10219904 |
1999 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) is the major mediator of the humoral hypercalcemia of malignancy and of malignant osteolysis associated with skeletal metastases of common epithelial cancers.
|
10942719 |
2000 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) is produced by various neoplasms and is known to be a causative factor of hypercalcemia of malignancy.
|
11029801 |
2000 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP), a factor responsible for malignancy associated hypercalcemia, plays a physiological roles such as bone development and placental calcium transport.
|
11813867 |
2002 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHRP) is in part responsible for the clinical syndrome of hypercalcaemia of malignancy and has been implicated as an important factor in the development of bone metastases.
|
12374685 |
2002 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) plays a primary role in the development of humoral hypercalcemia of malignancy seen in the majority of adult T-cell leukemia/lymphoma (ATLL) patients with human T-cell lymphotropic virus type-1 (HTLV-1) infection.
|
15889157 |
2005 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) came to the attention of the scientific community in the mid-1980s because of its association with the paraneoplastic syndrome of humoral hypercalcemia of malignancy.
|
16022632 |
2005 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
PTHrP appears as the major causative agent in humoral hypercalcemia of malignancy (HHM) associated to a broad range of tumors.
|
16223565 |
2006 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) and macrophage inflammatory protein-1 alpha (MIP-1 alpha) are important factors in the pathogenesis of HHM in ATLL and the expression of PTHrP can be activated by nuclear factor kappaB (NF-kappaB).
|
18089816 |
2007 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
PTHrP is produced by tumors associated with the syndrome of humoral hypercalcemia of malignancy giving rise to the parathyroid hormone (PTH)-like symptoms characteristic of the syndrome.
|
1935171 |
1991 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
PTHrP, a mediator of humoral hypercalcemia of malignancy, is considered as a potential activator to induce breast cancer cells metastasizing to bone.
|
20401668 |
2011 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
PTHrP's dysregulated expression has traditionally been associated with oncogenic pathologies as the major causative agent of malignancy-associated hypercalcemia, but recent evidence revealed a driving role in skeletal metastasis progression.
|
21901625 |
2011 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
PTHrP is also associated with the progression of skeletal metastases, and its dysregulated expression in advanced cancers causes malignancy-associated hypercalcemia.
|
22056386 |
2011 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) that causes hypercalcemia of malignancy appears to function as an endogenous smooth muscle relaxant.
|
28656682 |
2017 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHRP) is expressed in a large number of tumors and is the mediator of parathyroid hormone-like effects seen in humoral hypercalcemia of malignancy.
|
7692947 |
1993 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) is an important humoral factor in the syndrome of humoral hypercalcaemia of malignancy (HHM) and its importance is evident by the many studies examining either PTHrP mRNA expression, intracellular peptide, or circulating PTHrP levels in patients with malignancy.
|
8277370 |
1993 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
PTHrP gene amplification was also detected in one of five other tumors associated with humoral hypercalcemia of malignancy.
|
8768840 |
1996 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP), a major factor in the pathogenesis of humoral hypercalcemia of malignancy, is produced by many squamous carcinoma cells (SCCs).
|
8921834 |
1996 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
PTHrP was the causative factor for HHM in this case.
|
9042805 |
1997 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid hormone-related protein (PTHrP) is the cause of humoral hypercalcaemia of malignancy and interacts with parathyroid hormone (PTH) receptors.
|
9390035 |
1997 |
Humoral hypercalcemia of malignancy (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Parathyroid-hormone-related protein (PTHrP) is the main mediator of the humoral hypercalcemia of malignancy.
|
9422518 |
1998 |